Drug Shortage Report for TEVA-VORICONAZOLE
Report ID | 207545 |
Drug Identification Number | 02396866 |
Brand name | TEVA-VORICONAZOLE |
Common or Proper name | VORICONAZOLE 50MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | VORICONAZOLE |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30's |
ATC code | J02AC |
ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-10-11 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-02-03 |
Company comments | On Suspended Supply |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v22 | 2025-02-03 | French | Compare |
v21 | 2025-02-03 | English | Compare |
v20 | 2024-04-25 | French | Compare |
v19 | 2024-04-25 | English | Compare |
v18 | 2024-03-28 | French | Compare |
v17 | 2024-03-28 | English | Compare |
v16 | 2024-03-14 | French | Compare |
v15 | 2024-03-14 | English | Compare |
v14 | 2024-02-15 | French | Compare |
v13 | 2024-02-15 | English | Compare |
v12 | 2024-01-25 | French | Compare |
v11 | 2024-01-25 | English | Compare |
v10 | 2024-01-18 | French | Compare |
v9 | 2024-01-18 | English | Compare |
v8 | 2024-01-11 | French | Compare |
v7 | 2024-01-11 | English | Compare |
v6 | 2023-11-23 | French | Compare |
v5 | 2023-11-23 | English | Compare |
v4 | 2023-10-26 | French | Compare |
v3 | 2023-10-26 | English | Compare |